Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05515341 · ClinicalTrials.gov registry record

A DirEct to PatieNt Study in Chronic Pain

A clinical trial of Chronic Pain, sponsored by Boston Scientific Corporation.

Recruiting
Registry status
50,000
Enrollment target
1
Study location

NCT05515341 is a study of Chronic Pain that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 50,000 participants, above the 606-participant average among 301 other Chronic Pain trials with a reported enrollment target (8151% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05515341, a study of Chronic Pain, is actively recruiting participants, sponsored by Boston Scientific Corporation.

RECRUITING
Registry status
50,000 participants
Enrollment target
1
Study location

Study Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Conditions Studied

Interventions

  • DEVICE Commercially Approved Interventional Medical Device/Therapy for Chronic Pain

Study Locations (1)

California

  • Boston Scientific Neuromodulation - Valencia

Trial Details

FieldValue
Enrollment Target 50,000 participants
Start Date 2023-01-10
Est. Completion 2029-12

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT05515341

The ClinicalTrials.gov registry entry for NCT05515341 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 606-participant average among 301 other Chronic Pain trials with a reported enrollment target (8151% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Commercially Approved Interventional Medical Device/Therapy for Chronic Pain is the first listed.

NCT05515341 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05515341 about?

NCT05515341 is a clinical study titled "A DirEct to PatieNt Study in Chronic Pain". To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

What is the current status of trial NCT05515341?

This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2023-01-10. Estimated completion is 2029-12.

What conditions does trial NCT05515341 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT05515341?

The interventions under investigation include: Commercially Approved Interventional Medical Device/Therapy for Chronic Pain (DEVICE).

Who is sponsoring clinical trial NCT05515341?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05515341 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.